Regulus Therapeutics Inc

Regulus Therapeutics Inc. is a biopharmaceutical company. The Company focuses on the development of novel oligonucleotide therapeutics that are designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. Regulus Therapeutics operates in the United States.